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Dear Editor,
The coronavirus disease 2019 (COVID-19) is a severe
acute respiratory infection caused by a type of coronavirus
that first originated in Wuhan, China in December 2019
and quickly has spread all over the world causing the
COVID-19 pandemic (1, 2). COVID-19 is rapidly expanding
and has affected 304,622 people worldwide, of whom and
13,000 cases have died (death rate = 4.23) (3).
Most of the countries are currently affected by the
COVID-19 pandemic, which not only threatens the public
health but also affects many aspects of people’s lives, par-
ticularly the global economy (4). Several measures have
considered by different countries to deal with and control
COVID-19. Telemedicine services are one of the most effec-
tive ways to deal with and control COVID-19 pandemic (5).
Given the high risk of transmission of the disease through
person-to-person contact, telemedicine can be useful in
controlling the CoVID-19 by reducing direct contact. One of
the important applications of telemedicine is to follow up
patients after a hospital discharge (6), which can be used
for patients with COVID-19, as well. Accordingly, it can re-
duce the contact between patients and physicians and also
result in increased population surveillance.
Furthermore, one of the potentials of telemedicine is
supporting triage and sorting people susceptible to COVID-
19 before referral to hospitals (7). Using the televisiting and
teleconsultation can be helpful for remote visiting the vul-
nerable cases, disinfecting public places, and limiting un-
necessary trips. Televisiting also helps patients with CoVID-
19 to access their required health services and more pa-
tients can be visited by physicians (8).
One of the most vulnerable groups of people to the
CoVID-19 outbreak are those with chronic diseases and co-
morbidities (9). In these cases, regular referrals to the hos-
pital should be avoided by telemedicine services, such as
televisiting and teleconsultation.
Physicians and other healthcare providers at hospi-
tals are at a higher risk of CoVID-19 due to direct contact
with the patients. The physicians can use telemedicine ser-
vices to manage the patients with CoVID-19 remotely (10)
through remote access to the patient’s information, such
as laboratory test results, chest radiograph and CT find-
ings, and offering therapeutic measures based on these re-
sults to the nurses and other healthcare providers.
The teleconsultation system can be used to collect and
record patients’ information, such as fever, cough, and
other major symptoms through isolation and quarantine
periods (11), to have a complete database and provide bet-
ter monitoring of the society.
However, comprehensives measures should be taken
to deal with CoVID-19 considering all possible aspects, in
which different parts of the health system are involved. Ac-
cordingly, telemedicine can be used as one of the effective
strategies. This study briefly outlined the needs addressed
by telemedicine, including follow-up and monitoring pa-
tients after discharge, visiting susceptible cases, caring for
patients with chronic diseases and other comorbidities,
protecting physicians and other healthcare providers, and
data collection through quarantine and isolation periods.
All countries are recommended to use telemedicine capac-
ities to cope with CoVID-19 based on their national infras-
tructures.
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